Samuel U. Takvorian, MD, MS
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Headshot of Samuel U. Takvorian, MD, MS
Penn Medicine Provider

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Harvard Medical School
  • Residency: Mass General Brigham Healthcare Center - Chestnut Hill
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

767 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
has a excellent bedside manner
Anonymous
April 2026
there was no rush answered all of our questions. was personable
Anonymous
April 2026
great doctor.
Anonymous
April 2026
he was pleasant and complete

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Takvorian is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Aleixo G, Ani J, Ferrell WJ, Malik S, Peters S, Adams, Loreg M, Eckert A, Grant D, Perloff T, Syed M, Parikh RB, Gabriel P, Hughes S, Dotan E, Sedhom R, Takvorian SU. Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70): Protocol for a hybrid implementation-effectiveness study in three community oncology practices in the United States , Journal of Geriatric Oncology, 17(4): 2026


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist: 2026


Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713


Mo G, Maier S, Doyle M, Sweeney S, Orellana J, Farago L, Lloyd A, Mawema H, Bajaj A, Mei L, Takvorian SU, Haas NB, Ky B, Leong D, Narayan V. Cardiovascular risk evaluation in men with prostate cancer study (CARE-PC): Pilot study to assess patient awareness and risk mitigation. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA. : 2026


Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer , J Nucl Med: 2026


Aleixo G, Ani J, Raghavendran K, Zuber C, Goldman N, Gabriel P, Singh A, Boisseau L, Takvorian S, Dougherty D, Dotan E, Sedhom R. Embedding Geriatric Oncology in a Community Practice of an Academic Health System: Implementation, Outcomes, and End-of-Life Impact , JCO Oncol Pract: 2026


Wainwright JV, Song W, Toneff H, Kalman J, Takvorian S, Rendle K. Effects of Integrating a Chatbot into Lung Cancer Care on Patient Medication Self Efficacy , American Society of Preventative Oncology: 2025


Abigail Pepin, Abigail Doucette, Neha Vapiwala, Vivek Narayan, Samuel Takvorian, Sophia O’Brien, David Mankoff, Philipose Mulugeta, Neil K. Taunk Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castrate Resistant Prostate Cancer (mCRPC) , The Journal of Nuclear Medicine: 2025


Crawford TB, Tayeb M, Barrett E, Al-Saleem T, Kondam P, Hausler R, Symecko H, Orr C, Wolfe C, Mann D, Spielman K, Wong G, Haas N, Narayan V, Robinson K, Takvorian S, Wong YN, Sokolova A, Montgomery RB, Menendez C, Kelley MJ, Aiello LB, Garraway IP, Domchek SM, Maxwell KN. Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients , medRxiv: 2025


Aleixo G, Ani J, Ferrell WJ, Parikh RB, Gabriel P, Dotan E, Fernandes dos Santos Hughes S, Sedhom R, Takvorian SU. Practical geriatric assessment (PGA) implementation strategies and correlative evaluations (PACE-70): A hybrid implementation-effectiveness study in 3 community practices. , 2025 American Society of Clinical Oncology Annual Meeting, Chicago, IL.: 2025


View all publications